American International Group, Inc. Magenta Therapeutics, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.97 - $3.08 $14,408 - $45,750	-14,854 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.55 - $5.23 $2,664 - $5,465	-1,045 Reduced 6.57%	14,854 $43,000
Q4 2021 Feb 11, 2022	SELL	$4.43 - $8.33 $2,108 - $3,965	-476 Reduced 2.91%	15,899 $70,000
Q3 2021 Nov 12, 2021	SELL	$6.07 - $9.89 $2,361 - $3,847	-389 Reduced 2.32%	16,375 $119,000
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $45,862 - $66,490	4,699 Added 38.95%	16,764 $164,000

Q1 2021 May 07, 2021	BUY	$7.66 - $13.38 $237 - $414	31 Added 0.26%	12,065 $143,000
Q4 2020 Feb 12, 2021	SELL	$6.1 - $7.94 $2,104 - $2,739	-345 Reduced 2.79%	12,034 $94,000
Q3 2020 Nov 04, 2020	BUY	$6.52 - $8.94 $13,163 - $18,049	2,019 Added 19.49%	12,379 $84,000
Q2 2020 Aug 12, 2020	SELL	$6.18 - $10.76 $6,260 - $10,899	-1,013 Reduced 8.91%	10,360 $78,000
Q1 2020 May 04, 2020	SELL	$6.03 - $15.24 $3,961 - $10,012	-657 Reduced 5.46%	11,373 $71,000
Q4 2019 Feb 05, 2020	SELL	$9.07 - $15.84 $916 - $1,599	-101 Reduced 0.83%	12,030 $182,000
Q3 2019 Nov 08, 2019	SELL	$9.63 - $14.0 $2,417 - $3,514	-251 Reduced 2.03%	12,131 $124,000
Q2 2019 Aug 13, 2019	BUY	$13.4 - $17.67 $42,786 - $56,420	3,193 Added 34.75%	12,382 $183,000
Q1 2019 May 06, 2019	BUY	$5.7 - $19.7 $37,859 - $130,847	6,642 Added 260.78%	9,189 $151,000
Q4 2018 Feb 13, 2019	SELL	$5.57 - $11.65 $735 - $1,537	-132 Reduced 4.93%	2,547 $15,000
Q3 2018 Nov 09, 2018	BUY	$11.32 - $15.7 $30,326 - $42,060	2,679 New	2,679 $32,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.